Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Erik D. Brady"'
Publikováno v:
Journal of the Advanced Practitioner in Oncology
Autor:
Erik D Brady
Publikováno v:
Journal of continuing education in nursing. 46(11)
Few articles contemplate the need for good guidance in question item-writing in the continuing education (CE) space. Although many of the core principles of sound item design translate to the CE health education team, the need exists for specific exa
Autor:
William W. Brennessel, Victor G. Young, Jeffrey A. Crisp, M. Brett Meredith, Timothy P. Hanusa, Maren Pink, Erik D. Brady, Gordon T. Yee
Publikováno v:
Organometallics. 27:5464-5473
The magnetic properties of monomeric bis(indenyl)chromium(II) complexes are sensitive to the relative orientation of the ligands (staggered, eclipsed, or gauche), regardless of whether such a conformation is imposed by sterically bulky substituents o
Publikováno v:
Organometallics. 27:1612-1616
Treatment of the phosphonium salt [Me(t-Bu)P(C5Me4H)2]I with 2 equiv of KH produces the coordination polymer {K[Me(t-Bu)P(C5Me4)2](thf)}∞. If the phosphonium salt reacts with a single equivalent of...
Autor:
Diane E. Milenic, Hyun-Soon Chong, Baidoo Kwamena, Hyun A. Song, Thien Le, Erik D. Brady, Martin W. Brechbiel, Xiang Ma
Publikováno v:
Journal of Medicinal Chemistry. 51:118-125
An antibody-targeted radiation therapy (radioimmunotherapy, RIT) employs a bifunctional ligand that can effectively hold a cytotoxic metal with clinically acceptable complexation kinetics and stability while being attached to a tumor-specific antibod
Autor:
Erik D. Brady, Kayhan Garmestani, Diane E. Milenic, Joseph Flynn, Paul S. Albert, Alia Abdulla, Martin W. Brechbiel
Publikováno v:
Clinical Cancer Research. 13:1926-1935
Purpose: Recent studies from this laboratory with 212Pb-trastuzumab have shown the feasibility of targeted therapy for the treatment of disseminated peritoneal disease using 212Pb as an in vivo generator of 212Bi. The objective of the studies present
Autor:
Victor G. Young, Jeffrey A. Crisp, Gordon T. Yee, M. Brett Meredith, Benjamin E. Kucera, Timothy P. Hanusa, Erik D. Brady, Neil R. Brooks
Publikováno v:
Organometallics. 25:4945-4952
Previous work on bis(indenyl)chromium(II) complexes substituted with bulky groups (i-Pr, t-Bu, SiMe3) found that their spin state (S = 1 or 2) depended on the symmetry of the molecules. Complexes w...
Autor:
Diane E. Milenic, Candice Pfiester, Kayhan Garmestani, Hans Arora, Erik D. Brady, Hyun-Soon Chong, Martin W. Brechbiel
Publikováno v:
Nuclear Medicine and Biology. 33:459-467
Novel ligands cis-2,6-bis[N,N-bis(carboxymethyl)aminomethyl]-1-piperidineacetic acid (PIP-DTPA), cis-[(1R,11S)-6,9,15-Tris-carboxymethyl-3,6,9,15-tetraazabicyclo[9.3.1]pentadec-3-yl]-acetic acid (PIP-DOTA), cis-{2,7-bis-[bis-carboxymethyl-amino)-meth
Publikováno v:
Nuclear Medicine and Biology. 32:301-305
A simple and rapid procedure was developed for the purification of cyclotron-produced 203Pb via the 203Tl(d,2n) 203Pb reaction. A Pb(II) selective ion-exchange resin, with commercial name Pb Resin from Eichrom Technologies, Inc., was used to purify 2
Publikováno v:
Nuclear Medicine and Biology. 31:795-802
A simple, non-radioactive method for the determination of ligand-to-protein ratio (L/P) for novel ligand-antibody conjugates has been developed based on an exchange equilibrium with the purple Cu(II) complex of arsenazo III. The method requires a UV/